Doxecitine–doxribtimine for treating thymidine kinase 2 deficiency in people of any age ID6484

  • Awaiting development
  • GID-HST10063
  • Expected publication date: TBC

15025-Doxecitine-and-Doxribtimine-for-Thymidine-Kinase-2-Deficiency-V1.0-MAY24-NON-CONF.pdf (nihr.ac.uk)